Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Developing a Problem-solving Intervention to Improve Self-Management and Transition Readiness in Adolescents with Sickle Cell Disease.

Melita N, Diaz-Linhart Y, Kavanagh PL, Sobota A.

J Pediatr Nurs. 2019 May - Jun;46:26-32. doi: 10.1016/j.pedn.2019.02.006. Epub 2019 Feb 28.

PMID:
30826724
2.

Impact of Intranasal Fentanyl in Nurse Initiated Protocols for Sickle Cell Vaso-occlusive Pain Episodes in a Pediatric Emergency Department.

Akinsola B, Hagbom R, Zmitrovich A, Kavanagh PL, Ashkouti A, Simon HK, Fleming A, Jain S, Dampier C, Morris CR.

Am J Hematol. 2018 May 17. doi: 10.1002/ajh.25144. [Epub ahead of print] No abstract available.

3.

A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia.

Lewen MO, Kavanagh PL, Sobota AE.

Am J Hematol. 2017 Jun;92(6):E121-E122. doi: 10.1002/ajh.24727. Epub 2017 Apr 29. No abstract available.

4.

Improving the Management of Vaso-Occlusive Episodes in the Pediatric Emergency Department.

Kavanagh PL, Sprinz PG, Wolfgang TL, Killius K, Champigny M, Sobota A, Dorfman D, Barry K, Miner R, Moses JM.

Pediatrics. 2015 Oct;136(4):e1016-25. doi: 10.1542/peds.2014-3470. Epub 2015 Sep 21.

5.

Improvement in influenza vaccination rates in a pediatric sickle cell disease clinic.

Sobota AE, Kavanagh PL, Adams WG, McClure E, Farrell D, Sprinz PG.

Pediatr Blood Cancer. 2015 Apr;62(4):654-7. doi: 10.1002/pbc.25390. Epub 2014 Dec 24.

6.

Medication adherence among pediatric patients with sickle cell disease: a systematic review.

Walsh KE, Cutrona SL, Kavanagh PL, Crosby LE, Malone C, Lobner K, Bundy DG.

Pediatrics. 2014 Dec;134(6):1175-83. doi: 10.1542/peds.2014-0177. Epub 2014 Nov 17. Review.

7.

Pasteurized human donor milk use among US level 3 neonatal intensive care units.

Parker MG, Barrero-Castillero A, Corwin BK, Kavanagh PL, Belfort MB, Wang CJ.

J Hum Lact. 2013 Aug;29(3):381-9. doi: 10.1177/0890334413492909. Epub 2013 Jun 13.

PMID:
23764482
8.

Setting the agenda for quality improvement in pediatric sickle cell disease.

Kenyon CC, Kavanagh PL, Fiechtner LG, Textor TE, Wang CJ.

J Natl Med Assoc. 2012 Jul-Aug;104(7-8):337-41.

PMID:
23092048
9.

Management of children with sickle cell disease: a comprehensive review of the literature.

Kavanagh PL, Sprinz PG, Vinci SR, Bauchner H, Wang CJ.

Pediatrics. 2011 Dec;128(6):e1552-74. doi: 10.1542/peds.2010-3686. Epub 2011 Nov 28. Review.

PMID:
22123880
10.

Quality-of-care indicators for children with sickle cell disease.

Wang CJ, Kavanagh PL, Little AA, Holliman JB, Sprinz PG.

Pediatrics. 2011 Sep;128(3):484-93. doi: 10.1542/peds.2010-1791. Epub 2011 Aug 15.

PMID:
21844055
11.

Translating scientific advances to improved outcomes for children with sickle cell disease: a timely opportunity.

Raphael JL, Kavanagh PL, Wang CJ, Mueller BU, Zuckerman B.

Pediatr Blood Cancer. 2011 Jul 1;56(7):1005-8. doi: 10.1002/pbc.23059. Epub 2011 Feb 22.

PMID:
21488152
12.

Sickle cell disease-related pediatric medical expenditures in the U.S.

Amendah DD, Mvundura M, Kavanagh PL, Sprinz PG, Grosse SD.

Am J Prev Med. 2010 Apr;38(4 Suppl):S550-6. doi: 10.1016/j.amepre.2010.01.004.

PMID:
20331957
13.

Health care utilization and expenditures for privately and publicly insured children with sickle cell disease in the United States.

Mvundura M, Amendah D, Kavanagh PL, Sprinz PG, Grosse SD.

Pediatr Blood Cancer. 2009 Oct;53(4):642-6. doi: 10.1002/pbc.22069.

PMID:
19492318
14.

Quality indicators and quality assessment in child health.

Kavanagh PL, Adams WG, Wang CJ.

Arch Dis Child. 2009 Jun;94(6):458-63. doi: 10.1136/adc.2008.137893. Epub 2009 Mar 22. Review.

15.

Food insecurity and compensatory feeding practices among urban black families.

Feinberg E, Kavanagh PL, Young RL, Prudent N.

Pediatrics. 2008 Oct;122(4):e854-60. doi: 10.1542/peds.2008-0831.

16.

Communication of positive newborn screening results for sickle cell disease and sickle cell trait: variation across states.

Kavanagh PL, Wang CJ, Therrell BL, Sprinz PG, Bauchner H.

Am J Med Genet C Semin Med Genet. 2008 Feb 15;148C(1):15-22. doi: 10.1002/ajmg.c.30160.

PMID:
18200513
17.

Economic assessment of troglitazone as an adjunct to sulfonylurea therapy in the treatment of type 2 diabetes.

Caro JJ, Klittich WS, Raggio G, Kavanagh PL, O'Brien JA, Shomphe LA, Flegel KM, Copley-Merriman C, Sigler C.

Clin Ther. 2000 Jan;22(1):116-27.

PMID:
10688395
18.

Direct medical costs of complications resulting from type 2 diabetes in the U.S.

O'Brien JA, Shomphe LA, Kavanagh PL, Raggio G, Caro JJ.

Diabetes Care. 1998 Jul;21(7):1122-8.

PMID:
9653606

Supplemental Content

Loading ...
Support Center